Dr. Gary B. Fogel, Chief Executive Officer: Dr. Fogel joined Natural Selection, Inc. in 1998 after completing the Ph.D. in biology from the University of California at Los Angeles with a focus on the evolution and variability of histone proteins. While at UCLA, Dr. Fogel was a Fellow of the Center for the Study of Evolution and the Origin of Life and earned several teaching and research awards. Dr. Fogel's current research interests focus on the application of computational intelligence methods to problems in the biomedical sciences. He is currently investigating the use of these approaches for gene expression analysis, gene recognition, drug activity/toxicity prediction, structure analysis and similarity, sequence alignment, and biomedical pattern recognition. Dr. Fogel leads Natural Selection, Inc.'s efforts in chem- and bioinformatics.
Dr. Fogel is a senior member of the IEEE and member of Sigma Xi. Dr. Fogel currently serves as editor-in-chief of BioSystems and as an associate editor for IEEE Transactions on Evolutionary Computation. He co-edited a volume on Evolutionary Computation in Bioinformatics published in 2003 (Morgan Kaufmann) and has co-edited Computational Intelligence in Bioinformatics, published in 2008 (IEEE Press). Dr. Fogel served as technical co-chair for the 2001 and 2006 Congresses on Evolutionary Computation, program chair for the 2004 Congress on Evolutionary Computation, and as general chair for the 2004 and 2005 IEEE Symposia on Computational Intelligence in Bioinformatics and Computational Biology. He currently serves as conference chair for the 2010 IEEE Congress on Evolutionary Computation (www.wcci2010.org) to be held in Barcelona, Spain as part of the IEEE World Congress on Computational Intelligence and as finance chair for the 2010 IEEE Symposium on Computational Intelligence o Bioinformatics and Computational Biology. Dr. Fogel serves on the IEEE Computational Intelligence Society Executive Committee (ExCom) as Vice President for Conferences for the period 2010-2012.
Dr. Fogel's responsibilities as CEO are to provide leadership towards maintaining Natural Selection, Inc.'s excellence in real-world applications of computational intelligence methods. Dr. Fogel assists in developing and advancing a company strategic plan for its mission and objectives and promotes revenue, profitability, and growth. Dr. Fogel oversees business operations to ensure production efficiency, quality, service, and cost-effective management of resources. He assists in developing and authorizing company operational procedures, policies, and standards. These activities are coordinated with the company President, Mr. William Porto.
Selected
Publications Lames Sl, Salemi M, Galligan D, de Oliveira T, Fogel GB, Zhao L, Brown J, Morris A, Masliah E, McGrath MS (2009) "Extensive HIV-1 Intra-host Recombination in Tissus with Abnormal Histopathology," PLoS One. Hecht D and Fogel GB (2009) "A Novel in Silico Approach to Drug Discovery via Computational Intelligence," Journal of Chemical Information and Modeling, Vol. 49, pp. 1105-1121. Hecht D and Fogel GB (2009) "Computational Intelligence Methods for Docking Scores," Current Computer-Assisted Drug Design, Vol. 5, March 2009, pp. 56-68. Fogel GB, Corne DW, Pan Y (eds.) (2008) Computational Intelligence in Bioinformatics, Wiley-IEEE Press. Fogel GB, Lamers S, McGrath M, Salemi M (2008) "Prediction of R5, X4, and R5X4 HIV-1 Co-receptor Usage with Evolved Neural Networks," IEEE/ACM Transactions on Computational Biology and Bioinformatics. Apr.-Jun. Vol. 5(2), pp. 291-300. Davis N, Biddlecom N, Hecht D, Fogel GB (2008) "On the Relationship Between GC Content and the Number of Predicted MicroRNA Binding Sites by MicroInspector," Computational Biology and Chemistry, 2008 Mar 10 [Epub ahead of print] Hecht D, Cheung M, and Fogel GB (2008) "QSAR Using Evolved Neural Networks for the Inhibition of Mutant PfDHFR by Pyrimethamine Derivatives," BioSystems, Vol. 92(1), pp. 10-15. Fogel GB, Cheung M, Pittman E, Hecht D (2008) "Modeling the Inhibition of Quadruple Mutant Plasmodium falciparum Dihydrofolate Reductase by Pyrimethamine Derivatives," J. Comput. Aided. Mol. Des. Vol. 22 (1), pp. 29-38. Fogel GB, Cheung M, Pittman E, Hecht D (2008) "In silico Screening Against Wild-type and Mutant Plasmodium falciparum Dihydrofolate Reductase," J. Mol. Graph. Model. Vol. 26(7), pp. 1145-1152. Fogel GB, Weekes DG, Varga G, Dow ER, Harlow HB, Onyia JE, and Su C (2004) "Discovery of Sequence Motifs Related to Coexpression of Genes Using Evolutionary Computation," Nucleic Acids Research, Vol. 32:13, pp. 3826-3835. (.pdf) Fogel GB and Corne DW (2003) Evolutionary Computation in Bioinformatics, Morgan Kaufmann Publishers. For more information please see the NSI Publications Library or email Dr. Fogel at: gfogel [at] natural-selection [dot] com